Copper-Catalyzed Decarboxylative Cross-Coupling of Potassium Polyfluorobenzoates with Aryl Iodides and Bromides
作者:Rui Shang、Yao Fu、Yan Wang、Qing Xu、Hai-Zhu Yu、Lei Liu
DOI:10.1002/anie.200904916
日期:2009.11.23
For copper only: The decarboxylative cross‐coupling of readily accessible and nonvolatile potassiumpolyfluorobenzoates with aryliodides and bromides using a copper catalyst provides polyfluorobiaryls and polyfluorostilbenes in excellent yields (see scheme). Mechanistic analyses are reported for the title reaction.
[EN] DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS<br/>[FR] DERIVES DE DIHYDROBENZOFURANYLE ALCANAMINE SERVANT D'AGONISTES DE 5HT2C
申请人:WYETH CORP
公开号:WO2005044812A1
公开(公告)日:2005-05-19
Compounds of Formula (I) or pharmaceutically acceptable salts thereof are provided: Formula (I) which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia.
[EN] 1-FUNCTIONALIZED DIBENZOFURANS AND DIBENZOTHIOPHENES FOR ORGANIC LIGHT EMITTING DIODES (OLEDS)<br/>[FR] DIBENZOTHIOPHÈNES ET DIBENZOFURANNES FONCTIONNALISÉS EN 1 POUR DIODES ÉLECTROLUMINESCENTES ORGANIQUES (OLED)
申请人:IDEMITSU KOSAN CO
公开号:WO2016097983A1
公开(公告)日:2016-06-23
The present invention relates to compounds of formula(I), a process for their production and their use in electronic devices, especially electroluminescent devices. When used as charge transport material and/or host material for phosphorescent emitters in electroluminescent devices, the compounds of formula I may provide improved efficiency and reduced driving voltage of electroluminescent devices.
Dihydrobenzofuranyl alkanamine derivatives and methods for using same
申请人:Gross Laird Jonathan
公开号:US20050261347A1
公开(公告)日:2005-11-24
Compounds of formula 2 or pharmaceutically acceptable salts thereof are provided:
wherein each of R
1a
, R
2a
, R
3a
, Ar, y, and m are as defined herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, are used to treat a variety of central nervous system disorders such as schizophrenia.
Dihydrobenzofuranyl Alkanamine Derivatives and Methods for Using Same
申请人:Gross Jonathan Laird
公开号:US20090082434A1
公开(公告)日:2009-03-26
Compounds of Formula 1 or pharmaceutically acceptable salts thereof are provided:
which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia.